| Literature DB >> 34765467 |
Xi Chen1, Mingjie Zhang1, Yixiao Song1, Yiwen Luo1, Liping Wang1, Zhuoming Xu1, Nan Bao2.
Abstract
BACKGROUND: Effective nutrition programs are beneficial for nutritional recovery in infants. Few studies have focused on the effect of early high-energy feeding after open heart surgery. This study sought to assess the effects of early high-energy feeding in infants after congenital heart surgery.Entities:
Keywords: Congenital heart disease; high-energy nutrition; malnutrition; randomized controlled trial
Year: 2021 PMID: 34765467 PMCID: PMC8578776 DOI: 10.21037/tp-21-360
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Figure 1Flowchart for patient screening, randomization, and follow-up.
Baseline characteristics of the 244 patients
| Characteristic | Total (N=244) | Intervention group (N=124) | Control group (N=120) | P |
|---|---|---|---|---|
| Age (days) | 106.2±46.1 | 109.1±46.1 | 103.3±46.1 | 0.332 |
| Female sex, n (%) | 102 (41.8) | 48 (38.7) | 54 (45.0) | 0.319 |
| Weight (kg) | 4.5±0.9 | 4.7±0.9 | 4.4±0.9 | 0.065 |
| Height (cm) | 57.6±5.1 | 58.2±5.1 | 57.0±5.0 | 0.061 |
| WAZ | −2.68±1.04 | −2.61±0.99 | −2.75±1.09 | 0.277 |
| HAZ | −2.68±1.71 | −1.66±1.76 | −1.98±1.66 | 0.143 |
| WHZ | −1.74±1.67 | −1.81±1.59 | −1.68±1.76 | 0.549 |
| Cardiac diagnosis, n (%) | ||||
| VSD | 128 (52.5) | 66 (53.2) | 62 (51.7) | |
| CoA | 24 (9.8) | 13 (10.5) | 11 (9.2) | |
| DORV | 17 (7.0) | 4 (3.2) | 13 (10.8) | |
| CAVSD | 14 (5.7) | 9 (7.3) | 5 (4.2) | |
| TAPVC | 11 (4.5) | 8 (6.5) | 3 (2.5) | |
| ASD | 10 (4.1) | 3 (2.4) | 7 (5.7) | |
| TOF | 8 (3.3) | 5 (4.0) | 3 (2.5) | |
| TGA | 7 (2.9) | 2 (1.6) | 5 (4.2) | |
| Valvular disease | 6 (2.5) | 3 (2.4) | 3 (2.5) | |
| PA | 5 (2.0) | 3 (2.4) | 2 (1.7) | |
| PDA | 3 (1.2) | 1 (0.8) | 2 (1.7) | |
| ALCAPA | 2 (0.8) | 2 (1.6) | 0 (0) | |
| Other | 9 (3.7) | 4 (3.3) | 5 (3.5) | |
| RACHs-1 score (IQR) | 2 (2,3) | 2 (2,3) | 2 (2,3) | 0.721 |
VSD, ventricular septal defect; CoA, aortic coarctation; DORV, double outlet right ventricle; CAVSD, complete atrial ventricular septal defect; TGA, transposition of great arteries; ASD, atrial septal defect; TAPVC, total anomalous pulmonary venous connection; PA, pulmonary atresia; TOF, tetralogy of Fallot; PDA, patent ductus arteriosus; ALCAPA, the left coronary artery originates from the pulmonary artery; WAZ, weight-for-age z-score; HAZ, height-for-age z-score; WHZ, weight-for-height z-score; SD, standard deviation; RACHS-1, Risk Adjusted classification for congenital heart surgery 1; IQR, interquartile range.
WHZ, WAZ, HAZ, and other primary outcomes at discharge
| Outcomes | Intervention group (N=124) | Control group (N=120) | P |
|---|---|---|---|
| WHZ | −2.29±0.06 | −2.76±0.06 | <0.001* |
| WAZ | −3.08±0.05 | −3.43±0.05 | 0.005* |
| HAZ | −1.92±0.05 | −1.96±0.05 | 0.446* |
| Accumulated liquid volume (mL/kg/d) | −13.4±14.1 | −15.4±13.3 | 0.285 |
| Average calories (calories/kg/d) | 44.5±10.7 | 34.7±9.5 | <0.001 |
| Peak of calories (calories/kg/d) | 75.7±19.6 | 55.6±13.5 | <0.001 |
| Initial feeding time (h) | 12 (8, 15.75) | 22 (15, 33.75) | <0.001 |
*, the P value was adjusted by covariance analysis. WAZ, weight-for-age z-score; HAZ, height-for-age z-score; WHZ, weight-for-height z-score.
Ventilator support time, length of hospital stay, length of CICU stay, fluid management, and dietary status
| Outcomes | Intervention group (N=124) | Control group (N=120) | P |
|---|---|---|---|
| Ventilator support time (IQR), h | 25.7 (11.7, 53.4) | 31.6 (11.7, 81.3) | 0.116 |
| CICU length of stay (IQR), days | 5.5 [3, 7] | 5.5 [3, 8] | 0.503 |
| Hospital length of stay (IQR), days | 14 (10, 19) | 14.5 (11, 22.8) | 0.233 |
| Infection (%) | 4 (3.2) | 15 (12.5) | 0.007 |
Subgroup analysis of the delayed rehabilitation population.
| Outcomes | Intervention group (N=62) | Control group (N=60) | P |
|---|---|---|---|
| Ventilator support time (IQR), h | 36.8 (29.7, 83.78) | 80.3 (34.8, 136.28) | 0.004 |
| CICU length of stay (IQR), days | 7 [6, 9] | 8 (7, 10.8) | 0.045 |
| Hospital length of stay (IQR), days | 17 (13, 24.5) | 20 [14, 27] | 0.158 |
| Infection (%) | 3 (4.8%) | 15 (25%) | 0.002 |
| Accumulated liquid volume (mL/kg/d) | −21.0±10.7 | −23.1±11.2 | <0.001 |
| Average calories (calories/kg/d) | 45.1±11.0 | 35.0±10.0 | <0.001 |
| Peak of calories (calories/kg/d) | 77.2±20.0 | 55.9±15.9 | <0.001 |
Tolerance parameters
| Adverse effect | Intervention group (N=124) | Control group (N=120) | P |
|---|---|---|---|
| Ventosity (%) | 11 (8.9) | 13 (10.8) | 0.607 |
| Constipation (%) | 3 (2.4) | 2 (1.7) | 0.678 |
| Diarrhea (%) | 4 (3.2) | 4 (3.3) | 0.962 |
| Emesis (%) | 0 | 0 | – |
| Allergy (%) | 2 (1.6) | 0 | 0.162 |
| Change of formula (%) | 2 (1.6) | 13 (10.8) | 0.003 |